Top Story

Conventional, accelerated cross-linking yield similar outcomes

December 18, 2014

Conventional and accelerated corneal cross-linking had comparable anatomic and visual outcomes in treating keratoconus, according to study findings.

The prospective, randomized clinical trial included 153 eyes of 153 patients with progressive keratoconus; 76 eyes underwent conventional cross-linking (CXL) and 77 eyes underwent accelerated cross-linking. Mean patient age was 22.3 years in the conventional CXL group and 22.6 years in the accelerated CXL group.

Blog

Assessing, improving your physician management style, part 3

December 18, 2014
Finally, I’d like you to score yourself on the following quiz, filling in the blank lines with one of the following four words:“Always” — 3 points
“Sometimes” — 2…
thumbnail for video 3948296533001 Meeting News CoverageVideo

VIDEO: Macular therapeutics update

December 18, 2014
NEW YORK — Andrew Moshfeghi, MD, MBA, discusses recent advances in retina technology, as well as future developments, in his presentation from OSN New York.
Health Care Legislative and Regulatory Update

New year, new code: How to get paid for chronic care management in 2015, part 1

December 18, 2014
From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of today’s…
Publication Exclusive

Nuances involved in creation of type 1 bubble in pre-Descemet’s endothelial keratoplasty

December 18, 2014
Pre-Descemet’s endothelial keratoplasty is a variant of endothelial keratoplasty and involves the creation of a type 1 bubble with a 30-gauge needle attached to an…
More News Headlines »
Short Subjects

Presumed Ocular Juvenile Xanthogranuloma and Biopsy-Proven Cutaneous Mastocytosis Occurring Sequentially in a Young Boy

Journal of Pediatric Ophthalmology and Strabismus, Volume -2147483648
Online Only, December 12, 2014
Juvenile xanthogranuloma is a benign non-Langerhans cell histiocytosis characterized by skin lesions that tend to be…
More »
CME
j477

Rapid Response: Real World Use of Anti-VEGF Therapy - Clinical Experience Beyond Pivotal Trials

This activity is supported by an educational grant from Genentech, Inc.

Management of retinal vascular diseases with anti-VEGF therapy has been well-established through large-scale trials…
More »
Meeting News Coverage Video
thumbnail for video 3932502583001

VIDEO: Controversies in pterygium surgery

December 17, 2014
NEW YORK — At OSN New York, William B. Trattler, MD, dispels misconceptions about pterygium surgery.
More »